Industry News

Medicinal Mushrooms Go Mainstream: Opportunity and Responsibility

By VERDEUM Research Team · September 16, 2026

Medicinal Mushrooms Go Mainstream: Opportunity and Responsibility

A Category on the Rise

Once the preserve of traditional Chinese medicine and dedicated foragers, functional mushrooms are now in coffee blends, gummies, and mainstream capsules. The growth is real, and so are the growing pains.

The Quality Question Nobody Can Avoid

The defining debate in mushroom supplements is fruiting body versus mycelium on grain:

  • **Fruiting body extracts** are made from the mushroom itself and tend to carry higher beta-glucan levels.
  • **Mycelium-on-grain products** grow the fungal network on a grain substrate and can contain substantial leftover starch, which inflates polysaccharide readings that are not actually beta-glucans.

Honest labels disclose which they use and report beta-glucan content specifically, not just total polysaccharides.

What Buyers Are Learning To Ask

  • Is this a fruiting body or mycelium product?
  • What is the beta-glucan percentage, measured by an appropriate assay?
  • Was the material hot-water extracted, since many active compounds are locked in indigestible chitin without extraction?

The Responsibility of Scale

Mainstream reach means many first-time buyers who cannot yet tell a rigorous product from a starchy one. The brands that thrive long term will be those that educate rather than exploit that gap.

The Takeaway

Medicinal mushrooms have earned their moment. Protecting it means competing on verified potency, not just on trend.

← Back to the Journal